These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 19136139)

  • 1. Determination and prediction of xenoestrogens by recombinant yeast-based assay and QSAR.
    Li F; Chen J; Wang Z; Li J; Qiao X
    Chemosphere; 2009 Mar; 74(9):1152-7. PubMed ID: 19136139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling and structure-activity relationship of podophyllotoxin and its congeners.
    Naik PK; Alam A; Malhotra A; Rizvi O
    J Biomol Screen; 2010 Jun; 15(5):528-40. PubMed ID: 20460251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation and prediction employing the predictive squared correlation coefficient test set activity mean vs training set activity mean.
    Schüürmann G; Ebert RU; Chen J; Wang B; Kühne R
    J Chem Inf Model; 2008 Nov; 48(11):2140-5. PubMed ID: 18954136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR of antilipid peroxidative activity of substituted benzodioxoles using chemometric tools.
    Mitra I; Roy K; Saha A
    J Comput Chem; 2009 Dec; 30(16):2712-22. PubMed ID: 19399769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Support vector machine for SAR/QSAR of phenethyl-amines.
    Niu B; Lu WC; Yang SS; Cai YD; Li GZ
    Acta Pharmacol Sin; 2007 Jul; 28(7):1075-86. PubMed ID: 17588345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comments on the definition of the Q2 parameter for QSAR validation.
    Consonni V; Ballabio D; Todeschini R
    J Chem Inf Model; 2009 Jul; 49(7):1669-78. PubMed ID: 19527034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical external validation and consensus modeling: a QSPR case study for Koc prediction.
    Gramatica P; Giani E; Papa E
    J Mol Graph Model; 2007 Mar; 25(6):755-66. PubMed ID: 16890002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VSMP: a novel variable selection and modeling method based on the prediction.
    Liu SS; Liu HL; Yin CS; Wang LS
    J Chem Inf Comput Sci; 2003; 43(3):964-9. PubMed ID: 12767155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis.
    Zhu H; Tropsha A; Fourches D; Varnek A; Papa E; Gramatica P; Oberg T; Dao P; Cherkasov A; Tetko IV
    J Chem Inf Model; 2008 Apr; 48(4):766-84. PubMed ID: 18311912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local lazy regression: making use of the neighborhood to improve QSAR predictions.
    Guha R; Dutta D; Jurs PC; Chen T
    J Chem Inf Model; 2006; 46(4):1836-47. PubMed ID: 16859315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of solubility parameters using partial least square regression.
    Tantishaiyakul V; Worakul N; Wongpoowarak W
    Int J Pharm; 2006 Nov; 325(1-2):8-14. PubMed ID: 16839717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMACC: interpretable correlation descriptors for quantitative structure-activity relationships.
    Melville JL; Hirst JD
    J Chem Inf Model; 2007; 47(2):626-34. PubMed ID: 17381177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of cytotoxicity data (CC(50)) of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives by artificial neural network trained with Levenberg-Marquardt algorithm.
    Arab Chamjangali M; Beglari M; Bagherian G
    J Mol Graph Model; 2007 Jul; 26(1):360-7. PubMed ID: 17350867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative QSAR analyses of competitive CYP2C9 inhibitors using three-dimensional molecular descriptors.
    Lather V; Fernandes MX
    Chem Biol Drug Des; 2011 Jul; 78(1):112-23. PubMed ID: 21477091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
    Leonard JT; Roy K
    Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR study of 2-(1-Propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide as PARP inhibitors for treatment of cancer.
    Riahi S; Pourbasheer E; Dinarvand R; Ganjali MR; Norouzi P
    Chem Biol Drug Des; 2008 Dec; 72(6):575-84. PubMed ID: 19090924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional QSAR analyses of 1,3,4-trisubstituted pyrrolidine-based CCR5 receptor inhibitors.
    Zhuo Y; Kong R; Cong XJ; Chen WZ; Wang CX
    Eur J Med Chem; 2008 Dec; 43(12):2724-34. PubMed ID: 18538451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.